The generic drug user fee era has only just begun, but so far at least, it has not changed the tenor of the annual Generic Pharmaceutical Association-FDA Fall Technical Conference, which still features tough talk from the agency about generic drug quality problems.
FDA officials, including new Office of Generic Drugs Director Gregory Geba and Acting Office of Compliance Director Ilisa Bernstein, again...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?